Levin, M.J., Barber, D., Goldblatt, E., et al. (1998) Use of a Live Attenuated Varicella Vaccine to Boost Varicella-Specific Immune Responses in Seropositive People 55 Years of Age and Older: Duration of Booster Effect. The Journal of Infectious Diseases, 178, S109-S112.
https://doi.org/10.1086/514264

has been cited by the following article:

• TITLE: Herpes Zoster in Diverse Situations: A Review

  AUTHORS: Olatunde Peter Olabode, Oiwoh Sebastine, Adeolu Oladayo Akinboro

  KEYWORDS: Herpes Zoster, Post Herpetic Neuralgia, Immunocompromised, Malignan-cy, HIV

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.9 No.9, September 25, 2018

  ABSTRACT: Herpes zoster occurred when the suppressive ability of immune system failed to prevent the reactivation of initial varicella-zoster virus infection. Its frequency is higher among immune compromised individuals. Herpes zoster presents with characteristic painful grouped vesicles on erythematous background along the dermatome area and could be complicated by post-herpetic neuralgia. The current review examined the risk factors and discussed herpes zoster in different situations, treatment and concluded by discussing the future research trend of herpes zoster.